|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Li X, Wang J, Ma Y, Wang S, Yu X, Niu K,
Yan P, Wu D, Song J, Kou Y, et al: Burden and trends of early-onset
gastric cancer in the 11 BRICS countries (2025 expansion):
1990-2021 with projections to 2035. BMC Cancer. 25:14782025.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luzko I, Moreira L and Bornschein J:
Screening for and surveillance of premalignant conditions of the
stomach. Best Pract Res Clin Gastroenterol. 75:1019782025.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ko MT, Fung A, Kumar A, McArdle A and
Alexandre L: Post-endoscopy upper gastrointestinal cancer: Emerging
data and opportunities to improve early detection. Best Pract Res
Clin Gastroenterol. 75:1020032025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo D, Zhou J, Ruan S, Zhang B, Zhu H, Que
Y, Ying S, Li X, Hu Y and Song Z: Overcoming immunotherapy
resistance in gastric cancer: insights into mechanisms and emerging
strategies. Cell Death Dis. 16:752025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun Q, Li S, Lou J, Wang X and Xu X:
Recent advances in tumour microenvironment impact immunotherapy
resistance in gastric cancer. Crit Rev Oncol Hematol.
215:1048372025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vander Heiden MG, Cantley LC and Hompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schiliro C and Firestein BL: Mechanisms of
metabolic reprogramming in cancer cells supporting enhanced growth
and proliferation. Cells. 10:10562021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai H, Zhang F, Xu F and Yang C: Metabolic
reprogramming and therapeutic targeting in non-small cell lung
cancer: Emerging insights beyond the Warburg effect. Front Oncol.
15:15642262025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marei HE: Epigenetic regulators in cancer
therapy and progression. NPJ Precis Oncol. 9:2062025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Toden S, Zumwalt TJ and Goel A: Non-coding
RNAs and potential therapeutic targeting in cancer. Biochim Biophys
Acta Rev Cancer. 1875:1884912021. View Article : Google Scholar
|
|
13
|
Saw PE, Xu X, Chen J and Song E:
Non-coding RNAs: The new central dogma of cancer biology. Sci China
Life Sci. 64:22–50. 2021. View Article : Google Scholar
|
|
14
|
Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan
X, Lin A, Shu Q and Zhou T: Non-coding RNAs in gastric cancer.
Cancer Lett. 493:55–70. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Sun D, Pu W, Wang J and Peng Y:
Circular RNAs in cancer: Biogenesis, function, and clinical
significance. Trends Cancer. 6:319–336. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia L, Song M, Sun M, Wang F and Yang C:
Circular RNAs as biomarkers for cancer. Adv Exp Med Biol.
1087:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pandey PR, Munk R, Kundu G, De S,
Abdelmohsen K and Gorospe M: Methods for analysis of circular RNAs.
Wiley Interdiscip Rev RNA. 11:e15662020. View Article : Google Scholar
|
|
18
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He AT, Liu J, Li F and Yang BB: Targeting
circular RNAs as a therapeutic approach: Current strategies and
challenges. Signal Transduct Target Ther. 6:1852021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee K, Ku J, Ku D and Kim Y: Inverted Alu
repeats: Friends or foes in the human transcriptome. Exp Mol Med.
56:1250–1262. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar :
|
|
22
|
Wang S, Sun Z, Lei Z and Zhang H:
RNA-binding proteins and cancer metastasis. Semin Cancer Biol.
86:748–768. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galarneau A and Richard S: Target RNA
motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol
Biol. 12:691–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong H, An O, Chan THM, Ng VHE, Kwok HS,
Lin JS, Qi L, Han J, Tay DJT, Tang SJ, et al: Bidirectional
regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box
helicase 9 (DHX9) in cancer. Nucleic Acids Res. 46:7953–7969. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ivanov A, Memczak S, Wyler E, Torti F,
Porath HT, Orejuela MR, Piechotta M, Levanon EY, Landthaler M,
Dieterich C and Rajewsky N: Analysis of intron sequences reveals
hallmarks of circular RNA biogenesis in animals. Cell Rep.
10:170–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Warburg O: On respiratory impairment in
cancer cells. Science. 124:269–270. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ciccarone F and Ciriolo MR: Reprogrammed
mitochondria: A central hub of cancer cell metabolism. Biochem Soc
Trans. 52:1305–1315. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhan H, Pal DS, Borleis J, Deng Y, Long Y,
Janetopoulos C, Huang CH and Devreotes PN: Self-organizing
glycolytic waves tune cellular metabolic states and fuel cancer
progression. Nat Commun. 16:55632025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Liu S, Fu S, Zhao Q, Wang Y, Yuan
Y and Zhang C: Novel insight into the Warburg effect: Sweet
temptation. Crit Rev Oncol Hematol. 214:1048442025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qu J, Li P and Sun Z: Histone lactylation
regulates cancer progression by reshaping the tumor
microenvironment. Front Immunol. 14:12843442023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pavlova NN, Zhu J and Thompson CB: The
hallmarks of cancer metabolism: Still emerging. Cell Metab.
34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barba I, Carrillo-Bosch L and Seoane J:
Targeting the Warburg effect in cancer: Where do we stand? Int J
Mol Sci. 25:31422024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J,
Shu C, Wang B, Wang Z, Chen C, et al: Glucose homeostasis controls
N-acetyltransferase 10-mediated ac4C modification of HK2 to drive
gastric tumorigenesis. Theranostics. 15:2428–2450. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bian X, Jiang H, Meng Y, Li YP, Fang J and
Lu Z: Regulation of gene expression by glycolytic and gluconeogenic
enzymes. Trends Cell Biol. 32:786–799. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Campos M and Albrecht LV: Hitting the
sweet spot: How glucose metabolism is orchestrated in space and
time by phosphofructokinase-1. Cancers (Basel). 16:162023.
View Article : Google Scholar
|
|
37
|
Zhang Z, Han S, Ouyang S, Zeng Z, Liu Z,
Sun J and Kang W: PDK4 constitutes a novel prognostic biomarker and
therapeutic target in gastric cancer. Diagnostics (Basel).
12:11012022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang R, Mao G, Tang Y, Li C, Gao Y, Nie
W, Song T, Liu S, Zhang P, Tao K and Li W: Inhibition of glycolysis
enhances the efficacy of immunotherapy via PDK-mediated
upregulation of PD-L1. Cancer Immunol Immunother. 73:1512024.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu S, Guo Y, Zhang X, Liu H, Yin M, Chen
X and Peng C: Pyruvate kinase M2 (PKM2) in cancer and cancer
therapeutics. Cancer Lett. 503:240–248. 2021. View Article : Google Scholar
|
|
40
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Röhrig F and Schulze A: The multifaceted
roles of fatty acid synthesis in cancer. Nat Rev Cancer.
16:732–749. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Houten SM and Wanders RJ: A general
introduction to the biochemistry of mitochondrial fatty acid
β-oxidation. J Inherit Metab Dis. 33:469–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH,
Deng K and Yang JL: Lipid metabolic reprogramming in tumor
microenvironment: From mechanisms to therapeutics. J Hematol Oncol.
16:1032023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li C, Zhang L, Qiu Z, Deng W and Wang W:
Key molecules of fatty acid metabolism in gastric cancer.
Biomolecules. 12:7062022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guerrero-Rodríguez SL, Mata-Cruz C,
Pérez-Tapia SM and Velasco-Velázquez MA: Role of CD36 in cancer
progression, stemness, and targeting. Front Cell Dev Biol.
10:10790762022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hao J, Wang J, Guo H, Zhao Y, Sun H, Li Y,
Lai X, Zhao N, Wang X, Xie C, et al: CD36 facilitates fatty acid
uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun.
11:47652020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiang M, Wu N, Xu B, Chu Y, Li X, Su S,
Chen D, Li W, Shi Y, Gao X, et al: Fatty acid-induced CD36
expression via O-GlcNAcylation drives gastric cancer metastasis.
Theranostics. 9:5359–5373. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Severin M, Hansen RK, Rolver MG, Hels T,
Maeda K, Pardo LA and Pedersen SF: Tumor acidosis supports cancer
cell lipid uptake via a rapid transporter-independent mechanism. J
Cell Sci. 138:jcs2636882025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schlaepfer IR and Joshi M: CPT1A-mediated
fat oxidation, mechanisms, and therapeutic potential.
Endocrinology. 161:bqz0462020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pereyra AS, Rajan A, Ferreira CR and Ellis
JM: Loss of muscle carnitine palmitoyltransferase 2 prevents
diet-induced obesity and insulin resistance despite long-chain
acylcarnitine accumulation. Cell Rep. 33:1083742020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang C, Zhang C, Li X, Shen J, Xu Y, Shi
H, Mu X, Pan J, Zhao T, Li M, et al: CPT1A-mediated succinylation
of S100A10 increases human gastric cancer invasion. J Cell Mol Med.
23:293–305. 2019. View Article : Google Scholar :
|
|
52
|
Wang M, Yu W, Cao X, Gu H, Huang J, Wu C,
Wang L, Sha X, Shen B, Wang T, et al: Exosomal CD44 transmits lymph
node metastatic capacity between gastric cancer cells via
YAP-CPT1A-mediated FAO reprogramming. Front Oncol. 12:8601752022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang Y, Lu JH, Wang F, Wang YN, He MM, Wu
QN, Lu YX, Yu HE, Chen ZH, Zhao Q, et al: Inhibition of fatty acid
catabolism augments the efficacy of oxaliplatin-based chemotherapy
in gastrointestinal cancers. Cancer Lett. 473:74–89. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ma G, Zhang Z, Li P, Zhang Z, Zeng M,
Liang Z, Li D, Wang L, Chen Y, Liang Y and Niu H: Reprogramming of
glutamine metabolism and its impact on immune response in the tumor
microenvironment. Cell Commun Signal. 20:1142022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lieu EL, Nguyen T, Rhyne S and Kim J:
Amino acids in cancer. Exp Mol Med. 52:15–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang B, Pei J, Xu S, Liu J and Yu J: A
glutamine tug-of-war between cancer and immune cells: Recent
advances in unraveling the ongoing battle. J Exp Clin Cancer Res.
43:742024. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zou W, Han Z, Wang Z and Liu Q: Targeting
glutamine metabolism as a potential target for cancer treatment. J
Exp Clin Cancer Res. 44:1802025. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ying M, You D, Zhu X, Cai L, Zeng S and Hu
X: Lactate and glutamine support NADPH generation in cancer cells
under glucose deprived conditions. Redox Biol. 46:1020652021.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lu YX, Ju HQ, Liu ZX, Chen DL, Wang Y,
Zhao Q, Wu QN, Zeng ZL, Qiu HB, Hu PS, et al: ME1 regulates NADPH
homeostasis to promote gastric cancer growth and metastasis. Cancer
Res. 78:1972–1985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yu JC, Jiang ZM and Li DM: Glutamine: A
precursor of glutathione and its effect on liver. World J
Gastroenterol. 5:143–146. 1999. View Article : Google Scholar
|
|
61
|
Jiang B, Zhang J, Zhao G, Liu M, Hu J, Lin
F, Wang J, Zhao W, Ma H, Zhang C, et al: Filamentous GLS1 promotes
ROS-induced apoptosis upon glutamine deprivation via insufficient
asparagine synthesis. Mol Cell. 82:1821–1835.e6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jaune-Pons E and Vasseur S: Role of amino
acids in regulation of ROS balance in cancer. Arch Biochem Biophys.
689:1084382020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Byun JK, Park M, Lee S, Yun JW, Lee J, Kim
JS, Cho SJ, Jeon HJ, Lee IK, Choi YK and Park KG: Inhibition of
glutamine utilization synergizes with immune checkpoint inhibitor
to promote antitumor immunity. Mol Cell. 80:592–606.e8. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Caforio M, Sorino C, Iacovelli S,
Fanciulli M, Locatelli F and Folgiero V: Recent advances in
searching c-Myc transcriptional cofactors during tumorigenesis. J
Exp Clin Cancer Res. 37:2392018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gao P, Tchernyshyov I, Chang TC, Lee YS,
Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT and
Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial
glutaminase expression and glutamine metabolism. Nature.
458:762–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Xu E, Ji B, Jin K and Chen Y:
Branched-chain amino acids catabolism and cancer progression: Focus
on therapeutic interventions. Front Oncol. 13:12206382023.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Peng H, Wang Y and Luo W: Multifaceted
role of branched-chain amino acid metabolism in cancer. Oncogene.
39:6747–6756. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yang D, Liu H, Cai Y, Lu K, Zhong X, Xing
S, Song W, Zhang Y, Ye L, Zhu X, et al: Branched-chain amino acid
catabolism breaks glutamine addiction to sustain hepatocellular
carcinoma progression. Cell Rep. 41:1116912022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang L and Han J: Branched-chain amino
acid transaminase 1 (BCAT1) promotes the growth of breast cancer
cells through improving mTOR-mediated mitochondrial biogenesis and
function. Biochem Biophys Res Commun. 486:224–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kami K, Fujimori T, Sato H, Sato M,
Yamamoto H, Ohashi Y, Sugiyama N, Ishihama Y, Onozuka H, Ochiai A,
et al: Metabolomic profiling of lung and prostate tumor tissues by
capillary electrophoresis time-of-flight mass spectrometry.
Metabolomics. 9:444–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yu L, Bao S, Zhu F, Xu Y, Liu Y, Jiang R,
Yang C, Cao F, Chen W and Li P: Association between branched-chain
amino acid levels and gastric cancer risk: Large-scale prospective
cohort study. Front Nutr. 11:14798002024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lane AN and Fan TWM: Regulation of
mammalian nucleotide metabolism and biosynthesis. Nucleic Acids
Res. 43:2466–2485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Feng Q, Zhang W, Peng Y, Zhao C, Ren J and
Qu X: Precise targeting one-carbon metabolism for potent cancer
therapy and metastasis suppression. Small. 21:e046312025.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Malvi P, Bugide S, Dutta R, Reddi KK,
Edwards YJK, Singh K, Gupta R and Wajapeyee N: PDE7A inhibition
suppresses triple-negative breast cancer by attenuating de novo
pyrimidine biosynthesis. Cell Rep Med. 6:1023562025. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Mullen NJ and Singh PK: Nucleotide
metabolism: A pan-cancer metabolic dependency. Nat Rev Cancer.
23:275–294. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Tran DH, Kim D, Kesavan R, Brown H, Dey T,
Soflaee MH, Vu HS, Tasdogan A, Guo J, Bezwada D, et al: De novo and
salvage purine synthesis pathways across tissues and tumors. Cell.
187:3602–3618.e20. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yoon BK, Kim H, Oh TG, Oh SK, Jo S, Kim M,
Chun KH, Hwang N, Lee S, Jin S, et al: PHGDH preserves one-carbon
cycle to confer metabolic plasticity in chemoresistant gastric
cancer during nutrient stress. Proc Natl Acad Sci USA.
120:e22178261202023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Feng X, Ma D, Zhao J, Song Y, Zhu Y, Zhou
Q, Ma F, Liu X, Zhong M, Liu Y, et al: UHMK1 promotes gastric
cancer progression through reprogramming nucleotide metabolism.
EMBO J. 39:e1025412020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Shi DD, Savani MR, Abdullah KG and
McBrayer SK: Emerging roles of nucleotide metabolism in cancer.
Trends Cancer. 9:624–635. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Møller SH, Mellergaard M, Madsen M,
Bermejo AV, Jepsen SD, Hansen MH, Høgh RI, Aldana BI, Desler C,
Rasmussen LJ, et al: Cytoplasmic citrate flux modulates the immune
stimulatory NKG2D ligand MICA in cancer cells. Front Immunol.
11:19682020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ferrari de Andrade L, Tay RE, Pan D, Luoma
AM, Ito Y, Badrinath S, Tsoucas D, Franz B, May KF Jr, Harvey CJ,
et al: Antibody-mediated inhibition of MICA and MICB shedding
promotes NK cell-driven tumor immunity. Science. 359:1537–1542.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chen S and Wang Z: Integration of
mult-omics and nucleotide metabolism reprogramming signature
analysis reveals gastric cancer immunological and prognostic
features. Cancer Cell Int. 24:2122024. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Losenkova K, Zuccarini M, Karikoski M,
Laurila J, Boison D, Jalkanen S and Yegutkin GG:
Compartmentalization of adenosine metabolism in cancer cells and
its modulation during acute hypoxia. J Cell Sci. 133:jcs2414632020.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Antonioli L, Fornai M, Blandizzi C, Pacher
P and Haskó G: Adenosine signaling and the immune system: When a
lot could be too much. Immunol Lett. 205:9–15. 2019. View Article : Google Scholar
|
|
85
|
Haskó G, Linden J, Cronstein B and Pacher
P: Adenosine receptors: Therapeutic aspects for inflammatory and
immune diseases. Nat Rev Drug Discov. 7:759–770. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang M, Zhao X, Hou S, Wu Z and Yin HY:
Purinergic receptors in dendritic cells. J Inflamm Res.
18:13423–13432. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Pisignano G, Michael DC, Visal TH, Pirlog
R, Ladomery M and Calin GA: Going circular: History, present, and
future of circRNAs in cancer. Oncogene. 42:2783–2800. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Shahpari M, Hashemi M, Younesirad T,
Hasanzadeh A, Mosanne MM and Ahmadifard M: The functional roles of
competitive endogenous RNA (ceRNA) networks in apoptosis in human
cancers: The circRNA/miRNA/mRNA regulatory axis and cell signaling
pathways. Heliyon. 10:e370892024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Li H, Cao B, Zhao R, Li T, Xu X, Cui H,
Deng H, Gao J and Wei B: circDNMT1 promotes malignant progression
of gastric cancer through targeting miR-576-3p/hypoxia inducible
factor-1 alpha axis. Front Oncol. 12:8171922022. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Fang X, Bai Y, Zhang L and Ding S:
Silencing circSLAMF6 represses cell glycolysis, migration, and
invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer
under hypoxia. Biosci Rep. 40:BSR202012752020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Shen J and Zhu W: Research advances in the
role of gastric cancer-derived mesenchymal stem cells in tumor
progression (review). Int J Mol Med. 47:455–462. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang L, Wu C, Xu J, Gong Z, Cao X, Huang
J, Dong H, Zhu W, Huang F, Zhou C and Wang M: GC-MSC-derived
circ_0024107 promotes gastric cancer cell lymphatic metastasis via
fatty acid oxidation metabolic reprogramming mediated by the
miR-5572/6855-5p/CPT1A axis. Oncol Rep. 50:1382023. View Article : Google Scholar
|
|
93
|
Li F, Zhang L and Sun Q: CircAKT3 promotes
cell proliferation, survival and glutamine metabolism of gastric
cancer by activating SLC1A5 expression via targeting miR-515-5p.
Histol Histopathol. 37:227–241. 2022.
|
|
94
|
Ye B, Yu S, Wang J and Ren Y: CircB3GNTL1
and miR-598 regulation effects on proliferation, apoptosis, and
glutaminolysis in gastric cancer cells. Cell Mol Biol
(Noisy-le-grand). 66:18–23. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Li J, Zhang G and Wu G: Effect of paeonol
on proliferation, apoptosis, migration, invasion and glutamine of
gastric cancer cells via circSFMBT2/miR-665 axis. Cell Mol Biol
(Noisy-le-grand). 66:33–40. 2020. View Article : Google Scholar
|
|
96
|
Xu X, Wang S, Wang H, Pan C, Yang W and Yu
J: Hsa_circ_0008434 regulates USP9X expression by sponging
miR-6838-5p to promote gastric cancer growth, migration and
invasion. BMC Cancer. 21:12892021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kim GW, Cha M, Ong HTM, Yoo J, Jeon YH,
Lee SW, Oh SY, Kang MJ, Kim Y and Kwon SH: HDAC6 and USP9X control
glutamine metabolism by stabilizing GS to promote glioblastoma
tumorigenesis. Adv Sci (Weinh). 12:e25015532025. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Li L, Wei C, Xie Y, Su Y, Liu C, Qiu G,
Liu W, Liang Y, Zhao X, Huang D and Wu D: Expanded insights into
the mechanisms of RNA-binding protein regulation of circRNA
generation and function in cancer biology and therapy. Genes Dis.
12:1013832024. View Article : Google Scholar
|
|
99
|
Ji C, Zhu J, Hou X, Zhou C, Zhao J, Zheng
X and Tang Y: PTBP1 and cancer: From RNA regulation to therapeutic
potential. J Cell Mol Med. 29:e706752025. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Qian L, Wang L, Chen H, Wang S, Hou Y, Xu
L, Xia Y, Xu M and Huang X: Hsa_circ_0001756 drives gastric cancer
glycolysis by increasing the expression and stability of PGK1 mRNA.
Front Immunol. 16:15112472025. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Sun Q, Xing X, Wang H, Wan K, Fan R, Liu
C, Wang Y, Wu W, Wang Y and Wang R: SCD1 is the critical signaling
hub to mediate metabolic diseases: Mechanism and the development of
its inhibitors. Biomed Pharmacother. 170:1155862024. View Article : Google Scholar
|
|
102
|
Lin Z, Zhong C, Shi M, Long Q, Jing L, Yu
Y, Chou J, Chen M, Lan M and Long F: Circular RNA TFRC/SCD1 mRNA
interaction regulates ferroptosis and metastasis in gastric cancer.
Cell Death Dis. 16:4362025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Cellarier E, Durando X, Vasson MP, Farges
MC, Demiden A, Maurizis JC, Madelmont JC and Chollet P: Methionine
dependency and cancer treatment. Cancer Treat Rev. 29:489–499.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Li F, Liu P, Mi W, Li L, Anderson NM,
Lesner NP, Burrows M, Plesset J, Majer A, Wang G, et al: Blocking
methionine catabolism induces senescence and confers vulnerability
to GSK3 inhibition in liver cancer. Nat Cancer. 5:131–146. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Xin L, Zou YH, Liu CX, Lu H, Fan LJ, Xu
HS, Zhou Q, Liu J, Yue ZQ and Gan JH: Methionine restriction
promotes cisplatin sensitivity of gastric cancer resistant cells by
down-regulating circ-CDK13 level. Exp Cell Res. 443:1143152024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Xu AG, Li SG, Liu JH and Gan AH: Function
of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in
the development of gastric cancer. World J Gastroenterol.
7:403–406. 2001. View Article : Google Scholar
|
|
107
|
Calcagno DQ, Leal MF, Assumpcao PP, Smith
MAC and Burbano RR: MYC and gastric adenocarcinoma carcinogenesis.
World J Gastroenterol. 14:5962–5968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Cunningham JT, Moreno MV, Lodi A, Ronen SM
and Ruggero D: Protein and nucleotide biosynthesis are coupled by a
single rate-limiting enzyme, PRPS2, to drive cancer. Cell.
157:1088–1103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Yu T, Ran L, Zhao H, Yin P, Li W, Lin J,
Mao H, Cai D, Ma Q, Pan X, et al: Circular RNA circ-TNPO3
suppresses metastasis of GC by acting as a protein decoy for
IGF2BP3 to regulate the expression of MYC and SNAIL. Mol Ther
Nucleic Acids. 26:649–664. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Li H, Jiao W, Song J, Wang J, Chen G, Li
D, Wang X, Bao B, Du X, Cheng Y, et al: circ-hnRNPU inhibits
NONO-mediated c-Myc transactivation and mRNA stabilization
essential for glycosylation and cancer progression. J Exp Clin
Cancer Res. 42:3132023. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei
P, Liu H, Xu J, Xiao F, Zhou H, et al: A peptide encoded by
circular form of LINC-PINT suppresses oncogenic transcriptional
elongation in glioblastoma. Nat Commun. 9:44752018. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Jiang R, Li P, Meng E, Cheng X, Wu X and
Wu H: Hsa_Circ_0008035 drives immune evasion of gastric cancer via
promoting EXT1-mediated nuclear translocation of PKM2. Transl
Oncol. 48:1020042024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lu L, Guo G, Guo J, Li H, Chen K, Chen Y,
Li Q, Li Q, Diao Y, Sun M, et al: A novel protein encoded by
circUBE2G1 suppresses glycolysis in gastric cancer through binding
to ENO1. Cell Death Discov. 11:3502025. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Liu YY, Zhang YY, Ran LY, Huang B, Ren JW,
Ma Q, Pan XJ, Yang FF, Liang C, Wang XL, et al: A novel protein
FNDC3B-267aa encoded by circ0003692 inhibits gastric cancer
metastasis via promoting proteasomal degradation of c-Myc. J Transl
Med. 22:5072024. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Xiong L, Liu HS, Zhou C, Yang X, Huang L,
Jie HQ, Zeng ZW, Zheng XB, Li WX, Liu ZZ, et al: A novel protein
encoded by circINSIG1 reprograms cholesterol metabolism by
promoting the ubiquitin-dependent degradation of INSIG1 in
colorectal cancer. Mol Cancer. 22:722023. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Gao X, Sun Z, Liu X, Luo J, Liang X, Wang
H, Zhou J, Yang C, Wang T and Li J: 127aa encoded by circSpdyA
promotes FA synthesis and NK cell repression in breast cancers.
Cell Death Differ. 32:416–433. 2025. View Article : Google Scholar :
|
|
118
|
Wang J, Wang X, Yang C, Li Q, Li D, Du X,
Cheng Y, Tian M, Zheng L and Tong Q: circE2F1-encoded peptide
inhibits circadian machinery essential for nucleotide biosynthesis
and tumor progression via repressing SPIB/E2F1 axis. Int J Biol
Macromol. 280:1356982024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Hu H, Tang J, Wang H, Guo X, Tu C and Li
Z: The crosstalk between alternative splicing and circular RNA in
cancer: Pathogenic insights and therapeutic implications. Cell Mol
Biol Lett. 29:1422024. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zhou C, Molinie B, Daneshvar K, Pondick
JV, Wang J, Van Wittenberghe N, Xing Y, Giallourakis CC and Mullen
AC: Genome-wide maps of m6A circRNAs identify widespread and
cell-type-specific methylation patterns that are distinct from
mRNAs. Cell Rep. 20:2262–2276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Yi Q, Liao Y and Sun W, Li J, Yang D,
Shang H and Sun W: m6A modification of non-coding RNA: Mechanisms,
functions and potential values in human diseases (review). Int J
Mol Med. 56:1642025. View Article : Google Scholar
|
|
122
|
An Y and Duan H: The role of m6A RNA
methylation in cancer metabolism. Mol Cancer. 21:142022. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Wang T, Kong S, Tao M and Ju S: The
potential role of RNA N6-methyladenosine in cancer progression. Mol
Cancer. 19:882020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Yang Y, Fan X, Mao M, Song X, Wu P, Zhang
Y, Jin Y, Yang Y, Chen LL, Wang Y, et al: Extensive translation of
circular RNAs driven by N6-methyladenosine. Cell Res.
27:626–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zeng K, Peng J, Xing Y, Zhang L, Zeng P,
Li W, Zhang W, Pan Z, Zhou C and Lin J: A positive feedback circuit
driven by m6A-modified circular RNA facilitates
colorectal cancer liver metastasis. Mol Cancer. 22:2022023.
View Article : Google Scholar
|
|
126
|
Shan Z and Liu Y: Harnessing glycolysis in
gastric cancer: Molecular targets, therapeutic strategies, and
clinical horizons. Front Immunol. 16:16289372025. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang
Y, Yi C, Lindahl T, Pan T, Yang YG and He C: N6-methyladenosine in
nuclear RNA is a major substrate of the obesity-associated FTO. Nat
Chem Biol. 7:885–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wu X, Fang Y, Gu Y, Shen H, Xu Y, Xu T,
Shi R, Xu D, Zhang J, Leng K, et al: Fat mass and
obesity-associated protein (FTO) mediated m6A
modification of circFAM192A promoted gastric cancer proliferation
by suppressing SLC7A5 decay. Mol Biomed. 5:112024. View Article : Google Scholar
|
|
129
|
Liu J and Fang X: Regulation of
hsa_circ_0112136 by m6A demethylase FTO can enhance the malignancy
of gastric cancer via the regulation of the PI3K/AKT/mTOR pathway.
Biotechnol Appl Biochem. 71:1316–1328. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Villa E, Ali ES, Sahu U and Ben-Sahra I:
Cancer cells tune the signaling pathways to empower de novo
synthesis of nucleotides. Cancers (Basel). 11:6882019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Shi J, Mui S, Yan Y, Liu S, Wen K, He C,
Li H, Liao H, Tao M, Wen J, et al: m6A-modified
circRAPGEF1 interaction with IGF2BP3 promotes hepatocellular
carcinoma progression via reprogramming aspartate metabolism. Adv
Sci (Weinh). 12:e038512025. View Article : Google Scholar
|
|
132
|
Necula L, Matei L, Dragu D, Neagu AI,
Mambet C, Nedeianu S, Bleotu C, Diaconu CC and Chivu-Economescu M:
Recent advances in gastric cancer early diagnosis. World J
Gastroenterol. 25:2029–2044. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ott JJ, Ullrich A and Miller AB: The
importance of early symptom recognition in the context of early
detection and cancer survival. Eur J Cancer. 45:2743–2748. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Hazelton WD and Luebeck EG:
Biomarker-based early cancer detection: Is it achievable? Sci
Transl Med. 3:109fs92011. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Jacobson BC, Bhatt A, Greer KB, Lee LS,
Park WG, Sauer BG and Shami VM: ACG clinical guideline: Diagnosis
and management of gastrointestinal subepithelial lesions. Am J
Gastroenterol. 118:46–58. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng
G, Guo M, Lian X, Fan D and Zhang H: Diagnostic and prognostic
value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC
Cancer. 17:7372017. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer.
25:1–7. 2018. View Article : Google Scholar
|
|
139
|
Reis-das-Mercês L, Vinasco-Sandoval T,
Pompeu R, Ramos AC, Anaissi AKM, Demachki S, de Assumpção PP, Vidal
AF, Ribeiro-Dos-Santos  and Magalhães L: CircRNAs as potential
blood biomarkers and key elements in regulatory networks in gastric
cancer. Int J Mol Sci. 23:6502022. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W,
Yu R, Xiao B and Guo J: Plasma circular RNA profiling of patients
with gastric cancer and their droplet digital RT-PCR detection. J
Mol Med (Berl). 96:85–96. 2018. View Article : Google Scholar
|
|
141
|
Yang X, Xia J, Peng C and Cai W:
Expression of plasma exosomal circLPAR1 in patients with gastric
cancer and its clinical application value. Am J Cancer Res.
13:4269–4276. 2023.PubMed/NCBI
|
|
142
|
Rao M, Zhu Y, Qi L, Hu F and Gao P:
Circular RNA profiling in plasma exosomes from patients with
gastric cancer. Oncol Lett. 20:2199–2208. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Huang M, He YR, Liang LC, Huang Q and Zhu
ZQ: Circular RNA hsa_circ_0000745 may serve as a diagnostic marker
for gastric cancer. World J Gastroenterol. 23:6330–6338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Chen S, Li T, Zhao Q, Xiao B and Guo J:
Using circular RNA hsa_circ_0000190 as a new biomarker in the
diagnosis of gastric cancer. Clin Chim Acta. 466:167–171. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhao Q, Chen S, Li T, Xiao B and Zhang X:
Clinical values of circular RNA 0000181 in the screening of gastric
cancer. J Clin Lab Anal. 32:e223332018. View Article : Google Scholar
|
|
146
|
Ma Y, Li Z, Ma D, Guo J and Sun W:
Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of
gastric cancer. Int J Clin Oncol. 27:354–361. 2022. View Article : Google Scholar
|
|
147
|
Ma S, Kong S, Gu X, Xu Y, Tao M, Shen L,
Shen X and Ju S: As a biomarker for gastric cancer, circPTPN22
regulates the progression of gastric cancer through the EMT
pathway. Cancer Cell Int. 21:442021. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Shao Y, Yu X, Hu M, Yan J, Miao M, Ye G
and Guo J: Acting mechanism and clinical significance of
hsa_circ_0005927 in the invasion and metastasis of gastric cancer.
J Cancer. 15:4081–4094. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Shao Y, Tao X, Lu R, Zhang H, Ge J, Xiao
B, Ye G and Guo J: Hsa_circ_0065149 is an indicator for early
gastric cancer screening and prognosis prediction. Pathol Oncol
Res. 26:1475–1482. 2020. View Article : Google Scholar
|
|
150
|
Li WH, Song YC, Zhang H, Zhou ZJ, Xie X,
Zeng QN, Guo K, Wang T, Xia P and Chang DM: Decreased expression of
Hsa_circ_00001649 in gastric cancer and its clinical significance.
Dis Markers. 2017:45876982017. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Fang R, Yuan W, Mao C, Cao J, Chen H, Shi
X and Cong H: Human circular RNA hsa_circ_0000231 clinical
diagnostic effectiveness as a new tumor marker in gastric cancer.
Cancer Rep (Hoboken). 7:e20812024.PubMed/NCBI
|
|
152
|
Ma S, Yao Y, Xu Y, Zou M, Zhou M,
Abudushalamu G, Chen Y, Cai S, Zhang C and Wu G: Comprehensive
evaluation of serum circHAS2 as a novel diagnostic and prognostic
biomarker for gastric cancer. Mol Carcinog. 63:94–105. 2024.
View Article : Google Scholar
|
|
153
|
Yuan W, Fang R, Mao C, Chen H, Tai B and
Cong H: Serum circular RNA hsa_circ_0000702 as a novel biomarker
for diagnosis of gastric cancer. J Clin Lab Anal. 37:e248422023.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Zang X, Wang R, Wang Z, Qiu S, Zhang F,
Zhou L, Shen Y, Qian H, Xu W and Jiang J: Exosomal circ50547 as a
potential marker and promotor of gastric cancer progression via
miR-217/HNF1B axis. Transl Oncol. 45:1019692024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Huang XJ, Wang Y, Wang HT, Liang ZF, Ji C,
Li XX, Zhang LL, Ji RB, Xu WR, Jin JH and Qian H: Exosomal
hsa_circ_000200 as a potential biomarker and metastasis enhancer of
gastric cancer via miR-4659a/b-3p/HBEGF axis. Cancer Cell Int.
23:1512023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Gareev I, Ahmad A, Wang J, Beilerli A,
Ilyasova T, Sufianov A and Beylerli O: Gastric juice non-coding
RNAs as potential biomarkers for gastric cancer. Front Physiol.
14:11795822023. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Shao Y, Li J, Lu R, Li T, Yang Y, Xiao B
and Guo J: Global circular RNA expression profile of human gastric
cancer and its clinical significance. Cancer Med. 6:1173–1180.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Arnaiz E, Sole C, Manterola L,
Iparraguirre L, Otaegui D and Lawrie CH: CircRNAs and cancer:
Biomarkers and master regulators. Semin Cancer Biol. 58:90–99.
2019. View Article : Google Scholar
|
|
159
|
Roy S, Kanda M, Nomura S, Zhu Z, Toiyama
Y, Taketomi A, Goldenring J, Baba H, Kodera Y and Goel A:
Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy
biomarkers for early detection of gastric cancer. Mol Cancer.
21:422022. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Xu J, Liu Y, Zhang J, Yang S, Li T, Huang
H, Liu Q, Wang H, Cao L, An Z, et al: Single-droplet dual-target
quantification of circRNA biomarkers for colorectal cancer
screening. Adv Sci (Weinh). 12:e061592025. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Yang L, Wilusz JE and Chen LL: Biogenesis
and regulatory roles of circular RNAs. Annu Rev Cell Dev Biol.
38:263–289. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Szabo L and Salzman J: Detecting circular
RNAs: Bioinformatic and experimental challenges. Nat Rev Genet.
17:679–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Porwal O, Visht S and Muhammed RA:
Circular RNAs as biomarkers and targets in ovarian cancer. Clin
Chim Acta. 582:1208022026. View Article : Google Scholar
|
|
164
|
Guria A, Sharma P, Srikakulam N, Baby A,
Natesan S and Pandi G: Cost-effective transcriptome-wide profiling
of circular RNAs by the improved-tdMDA-NGS method. Front Mol
Biosci. 9:8863662022. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Saadh MJ, Ahmed HH, Kareem RA, Bishoyi AK,
Roopashree R, Shit D, Arya R, Joshi KK, Sameer HN, Yaseen A, et al:
The hidden messengers: Tumor microenvironment-derived exosomal
ceRNAs in gastric cancer progression. Pathol Res Pract.
269:1559052025. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Ferda J, Ferdová E, Vítovec M, Glanc D and
Mírka H: The imaging of the hypoxic microenvironment in tumorous
tissue using PET/CT and PET/MRI. Eur J Radiol. 154:1104582022.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Zandieh MA, Farahani MH, Rajabi R, Avval
ST, Karimi K, Rahmanian P, Razzazan M, Javanshir S, Mirzaei S,
Paskeh MDA, et al: Epigenetic regulation of autophagy by non-coding
RNAs in gastrointestinal tumors: Biological functions and
therapeutic perspectives. Pharmacol Res. 187:1065822023. View Article : Google Scholar
|
|
168
|
Barati T, Mirzaei Z, Abarghooi Kahaki F
and Afkhami H: Regulatory roles of ncRNAs in gastric cancer
progression: A comprehensive insight into key signaling pathways.
Med Oncol. 42:3092025. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Liu Y, Jiang Y, Xu L, Qu C, Zhang L, Xiao
X, Chen W, Li K, Liang Q and Wu H: circ-NRIP1 promotes glycolysis
and tumor progression by regulating miR-186-5p/MYH9 axis in gastric
cancer. Cancer Manag Res. 12:5945–5956. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Xu G, Li M, Wu J, Qin C, Tao Y and He H:
Circular RNA circNRIP1 sponges microRNA-138-5p to maintain
hypoxia-induced resistance to 5-fluorouracil through
HIF-1α-dependent glucose metabolism in gastric carcinoma. Cancer
Manag Res. 12:2789–2802. 2020. View Article : Google Scholar
|
|
171
|
Cordani M, Dando I, Ambrosini G and
González-Menéndez P: Signaling, cancer cell plasticity, and
intratumor heterogeneity. Cell Commun Signal. 22:2552024.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Golestanifar A, Zakeri M, Gohari-Lasaki S,
Khedri H and Saberiyan M: Combined bulk and single-cell
transcriptomic analysis reveals cell-type-specific inflammatory
crosstalk in pancreatic cancer. Clin Exp Med. 25:2632025.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Li Y, Xu Q, Wu D and Chen G: Exploring
additional valuable information from single-cell RNA-Seq data.
Front Cell Dev Biol. 8:5930072020. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Aquino-Jarquin G: CircRNA knockdown based
on antisense strategies. Drug Discov Today. 29:1040662024.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Zhou Y, Zhang Q, Liao B, Qiu X, Hu S and
Xu Q: circ_0006089 promotes gastric cancer growth, metastasis,
glycolysis, and angiogenesis by regulating miR-361-3p/TGFB1. Cancer
Sci. 113:2044–2055. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Jiang SF and Li RR: hsa_circ_0067514
suppresses gastric cancer progression and glycolysis via
miR-654-3p/LATS2 axis. Neoplasma. 69:1079–1091. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Shen X, Zhu X, Hu P, Ji T, Qin Y and Zhu
J: Knockdown circZNF131 inhibits cell progression and glycolysis in
gastric cancer through miR-186-5p/PFKFB2 axis. Biochem Genet.
60:1567–1584. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Yang X, Li D, Sun Y, Yi L, Chen Q and Lai
Y: CircFLNA facilitates gastric cancer cell proliferation and
glycolysis via regulating SOX5 by sponging miR-1200. Arab J
Gastroenterol. 25:369–377. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Wang Y, Cao B, Zhao R, Li H, Wei B and Dai
G: Knockdown of circBFAR inhibits proliferation and glycolysis in
gastric cancer by sponging miR-513a-3p/hexokinase 2 axis. Biochem
Biophys Res Commun. 560:80–86. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Zheng X, Shao J, Qian J and Liu S:
circRPS19 affects HK2-mediated aerobic glycolysis and cell
viability via the miR-125a-5p/USP7 pathway in gastric cancer. Int J
Oncol. 63:982023. View Article : Google Scholar
|
|
181
|
Chen L, Chi K, Xiang H and Yang Y:
Circ_0032821 facilitates gastric cancer cell proliferation,
migration, invasion and glycolysis by regulating MiR-1236-3p/HMGB1
axis. Cancer Manag Res. 12:9965–9976. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Liu J, Li J, Su Y, Ma Z, Yu S and He Y:
Circ_0009910 serves as miR-361-3p sponge to promote the
proliferation, metastasis, and glycolysis of gastric cancer via
regulating SNRPA. Biochem Genet. 60:1809–1824. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Zheng X, Xiao H, Liu X, Huang T and Deng
C: Exosomal circKIAA1797 regulates cell progression and glycolysis
by targeting miR-4429/PBX3 pathway in gastric cancer. Biochem
Genet. 62:1762–1778. 2024. View Article : Google Scholar
|
|
184
|
Zhao X, Tian Z and Liu L: circATP2B1
promotes aerobic glycolysis in gastric cancer cells through
regulation of the miR-326 gene cluster. Front Oncol. 11:6286242021.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Chen W and Ji Y: CircC6orf132 facilitates
proliferation, migration, invasion, and glycolysis of gastric
cancer cells under hypoxia by acting on the miR-873-5p/PRKAA1 axis.
Front Genet. 12:6363922021. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Yang J, Zhang X, Cao J, Xu P, Chen Z, Wang
S, Li B, Zhang L, Xie L, Fang L and Xu Z: Circular RNA UBE2Q2
promotes malignant progression of gastric cancer by regulating
signal transducer and activator of transcription 3-mediated
autophagy and glycolysis. Cell Death Dis. 12:9102021. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Liu J, Liu H, Zeng Q, Xu P, Liu M and Yang
N: Circular RNA circ-MAT2B facilitates glycolysis and growth of
gastric cancer through regulating the miR-515-5p/HIF-1α axis.
Cancer Cell Int. 20:1712020. View Article : Google Scholar
|
|
188
|
Ou W, Tan R, Zhai J, Sun L, Quan Z, Huang
X, Xu F, Xu Q and Zhou C: Silencing circ_0043256 inhibited
CoCl2-induced proliferation, migration, and aerobic glycolysis in
gastric cancer cells. Sci Rep. 15:1712025. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Lu Y, Cheng J, Cai W, Zhuo H, Wu G and Cai
J: Inhibition of circRNA circVPS33B reduces warburg effect and
tumor growth through regulating the miR-873-5p/HNRNPK axis in
infiltrative gastric cancer. Onco Targets Ther. 14:3095–3108. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Qu J, Yang J, Chen M, Wei R and Tian J:
CircFLNA acts as a sponge of miR-646 to facilitate the
proliferation, metastasis, glycolysis, and apoptosis inhibition of
gastric cancer by targeting PFKFB2. Cancer Manag Res. 12:8093–8103.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Lan ZZ, Sun FH, Chen C, Niu L, Shi JD and
Zhang WY: CircPRDM5 inhibits the proliferation, migration,
invasion, and glucose metabolism of gastric cancer cells by
reducing GCNT4 expression in a miR-485-3p-dependent manner.
Kaohsiung J Med Sci. 40:231–243. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Lu J, Zhou Y, Chen Z, Jiang H, Li J and
Dou G: Circ_0000419 acts as a tumor suppressor in gastric cancer
development via regulating miR-300/RGMB axis. Int J Clin Oncol.
28:1475–1485. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Wu G, Zhang A, Yang Y and Wu D:
Circ-RNF111 aggravates the malignancy of gastric cancer through
miR-876-3p-dependent regulation of KLF12. World J Surg Oncol.
19:2592021. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Ji Z, Diao W and Shang J: Circular RNA
circ_0000592 elevates ANXA4 expression via sponging miR-1179 to
facilitate tumor progression in gastric cancer. Anticancer Drugs.
33:e644–e654. 2022. View Article : Google Scholar
|
|
195
|
Pu Z, Xu M, Yuan X, Xie H and Zhao J:
Circular RNA circCUL3 accelerates the warburg effect progression of
gastric cancer through regulating the STAT3/HK2 axis. Mol Ther
Nucleic Acids. 22:310–318. 2020. View Article : Google Scholar : PubMed/NCBI
|
